** Shares of lab operator Quest Diagnostics DGX.N rise 6.7% to $172.67 premarket
** DGX posts Q1 adj. profit of $2.21 per share helped by robust demand for its diagnostic tests, beating analysts' estimates of $2.15, according to data compiled by LSEG
** Company reports Q1 revenue of $2.65 billion vs estimates of $2.63 billion
** Company continues to expect annual adj. profit in the range of $9.55 and $9.80 per share vs estimates of $9.68
** DGX maintains its annual net revenue forecast in the range of $10.70 billion to $10.85 billion vs estimates of $10.78 billion
** As of last close, DGX had risen 7.3% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.